Targeting Lectins Using mRNA Display with Genetic Reprogramming (129391)
Yichen Zhong
1
,
Jason J Johansen-Leete
1
,
Beiyuan Cui
1
,
Caitlin E Shepperson
1
,
Daniel J Ford
1
,
Toby Passioura
1
,
Richard J Payne
1
- School of Chemistry, University of Sydney, Sydney, NSW, Australia
Publish consent withheld
- (1) Cho, S. H.; Park, J. Y.; Kim, C. H. Systemic Lectin-Glycan Interaction of Pathogenic Enteric Bacteria in the Gastrointestinal Tract. Int J Mol Sci 2022, 23 (3). DOI: 10.3390/ijms23031451 From NLM Medline.
- (2) Geijtenbeek, T. B. H.; van Kooyk, Y. DC-SIGN: A novel HIV receptor on DCs that mediates HIV-1 transmission. Curr Top Microbiol 2003, 276, 31-54.
- (3) Silva, M. L. S. Lectin-modified drug delivery systems - Recent applications in the oncology field. Int J Pharm 2024, 665, 124685. DOI: 10.1016/j.ijpharm.2024.124685 From NLM Medline.
- (4) Goto, Y.; Suga, H. The RaPID Platform for the Discovery of Pseudo-Natural Macrocyclic Peptides. Acc Chem Res 2021, 54 (18), 3604-3617. DOI: 10.1021/acs.accounts.1c00391 From NLM Medline.